» Articles » PMID: 6607975

Chronic Lymphocytic Leukemia and Other Chronic Lymphoid Proliferations: Surface Marker Phenotypes and Clinical Correlations

Overview
Journal J Clin Oncol
Specialty Oncology
Date 1983 Mar 1
PMID 6607975
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A diagnosis of chronic lymphocytic leukemia (CLL) was made in 81 patients referred for peripheral blood lymphocyte typing (PBL). A retrospective review was undertaken to see if correlations existed between surface marker phenotype-determined subclasses and clinical features. Surface markers utilized were surface immunoglobulin (sIg), sheep erythrocyte receptor (E), 65,000-dalton human T lymphocyte antigen (T65), Ia antigen, and for sIg+ cells, heavy and light chains. All patients were Ia+. Cells of 70% of patients were sIg+ E- T65+ Ia+, and the clinical heterogeneity was that of classical CLL. Eight of the nine patients with sIg+ E- T65- Ia+ cells had a paraprotein. The sIg- E+ T65+ Ia+ phenotype represented classical T cell CLL. Three of the five patients in the sEg- E- T65+ Ia+ group had significant albuminuria, and two had nephrotic-range proteinuria. Use of additional monoclonal antibodies to B cell surface antigens should further subclassify CLL and other lymphoproliferative disorders. Interesting clinical correlations with certain phenotypic subclasses do exist, and further subclassification and long-term follow-up may yield correlations between phenotypes and prognosis.

Citing Articles

"Well-differentiated" lymphocytic neoplasms. Immunologic findings correlated with clinical presentation and morphologic features.

Medeiros L, Strickler J, Picker L, Gelb A, Weiss L, Warnke R Am J Pathol. 1987; 129(3):523-35.

PMID: 3322023 PMC: 1899809.


Repeated pentostatin (2'deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia.

Dillman R, Yu A, Qiao C West J Med. 1988; 148(3):334-7.

PMID: 3259051 PMC: 1026115.


Characterization of chronic lymphocytic leukemia (CLL) cells with low density of surface membrane bound immunoglobulins (smIg).

Kimby E, Axelsson B, Bjorkholm M, Gordon J, Holm G, Mellstedt H Med Oncol Tumor Pharmacother. 1985; 2(4):261-7.

PMID: 2935687 DOI: 10.1007/BF02934912.


Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience.

Borowitz M, Bousvaros A, Brynes R, Cousar J, Crissman J, Whitcomb C Am J Pathol. 1985; 121(3):514-21.

PMID: 2933960 PMC: 1887919.